Control Bionics Limited (ASX:CBL)
0.0630
-0.0030 (-4.55%)
Oct 9, 2026, 2:35 PM AEST
Control Bionics Revenue
In the fiscal year ending June 30, 2026, Control Bionics had annual revenue of 4.77M AUD, down -22.43%. Control Bionics had revenue of 1.95M in the half year ending June 30, 2026, a decrease of -18.43%. That makes Control Bionics the 41,151st largest company in the world by revenue and 810th in Australia.
Revenue
4.77M
Revenue Growth
-22.43%
P/S Ratio
7.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
34.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.77M | -1.38M | -22.43% |
| Jun 30, 2025 | 6.14M | 794.13K | 14.84% |
| Jun 30, 2024 | 5.35M | -291.61K | -5.17% |
| Jun 30, 2023 | 5.64M | 1.14M | 25.33% |
| Jun 30, 2022 | 4.50M | 413.43K | 10.11% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SomnoMed | 114.53M |
| Compumedics | 61.88M |
| Nova Eye Medical | 34.87M |
| Cyclopharm | 34.42M |
| CleanSpace Holdings | 19.82M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| OncoSil Medical | 5.09M |